| Sample | Title | Value | Rank |
|---|
| GSM780707 | Untreated after 4 days (C1_1) | 672.468 | 93 |
| GSM780708 | Untreated after 4 days (C2_1) | 677.381 | 94 |
| GSM780709 | Untreated after 4 days (C3_1) | 530.296 | 92 |
| GSM780719 | Untreated after 4 days (C1_2) | 601.88 | 93 |
| GSM780720 | Untreated after 4 days (C2_2) | 706.83 | 94 |
| GSM780721 | Untreated after 4 days (C3_2) | 540.798 | 92 |
| GSM780710 | Trastuzumab treated after 4 days (T1_1) | 621.873 | 93 |
| GSM780711 | Trastuzumab treated after 4 days (T2_1) | 657.315 | 93 |
| GSM780712 | Trastuzumab treated after 4 days (T3_1) | 841.347 | 95 |
| GSM780722 | Trastuzumab treated after 4 days (T1_2) | 700.725 | 94 |
| GSM780723 | Trastuzumab treated after 4 days (T2_2) | 632.813 | 93 |
| GSM780724 | Trastuzumab treated after 4 days (T3_2) | 857.454 | 95 |
| GSM780713 | Pertuzumab treated after 4 days (P1_1) | 605.684 | 93 |
| GSM780714 | Pertuzumab treated after 4 days (P2_1) | 560.106 | 92 |
| GSM780715 | Pertuzumab treated after 4 days (P3_1) | 715.352 | 94 |
| GSM780725 | Pertuzumab treated after 4 days (P1_2) | 627.389 | 93 |
| GSM780726 | Pertuzumab treated after 4 days (P2_2) | 650.838 | 93 |
| GSM780727 | Pertuzumab treated after 4 days (P3_2) | 660.028 | 93 |
| GSM780716 | Trastuzumab and Pertuzumab treated after 4 days (TP1_1) | 733.948 | 94 |
| GSM780717 | Trastuzumab and Pertuzumab treated after 4 days (TP2_1) | 700.515 | 94 |
| GSM780718 | Trastuzumab and Pertuzumab treated after 4 days (TP3_1) | 740.376 | 94 |
| GSM780728 | Trastuzumab and Pertuzumab treated after 4 days (TP1_2) | 721.668 | 94 |
| GSM780729 | Trastuzumab and Pertuzumab treated after 4 days (TP2_2) | 695.174 | 94 |